Rocket Pharmaceuticals Highlights Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301

  • Jonathan Schwartz,

Press/Media

Period3 Apr 2021

Media coverage

1

Media coverage

  • TitleRocket Pharmaceuticals Highlights Updated Positive Preliminary Clinical Data from Phase 1 Trial of RP-L301
    Media name/outletManufacturing Close-Up
    Country/TerritoryUnited States
    Date3/04/21
    PersonsJonathan Schwartz,
View all 1
View less